Features of Management of Patients with Acute Coronary Syndrome After Suffering Covid-19
Abstract
The novel coronavirus infection (COVID-19) pandemic, spread by the SARSCoV-2 virus, is a challenge to healthcare systems around the world. The most common manifestation of COVID-19 is the respiratory system. However, this disease is characterized by high activity of inflammation and thrombotic complications leading to multiple organ damage. Management of a patient with COVID-19 includes not only the treatment of pneumonia and respiratory failure, but also the timely recognition and treatment of damage to other target organs. An analysis of the factors associated with the severe course and poor prognosis of COVID-19 indicates the important role of comorbid pathology. Conditions that are associated with poor prognosis include cardiovascular disease in particular and acute coronary syndrome. This means that preventive measures during the COVID19 pandemic should consist of both measures to prevent infection and measures aimed at optimal control of these conditions. In our article, we outlined our point of view on this pathology.
References
2. Vremennye metodicheskie rekomendacii. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19) versiya 7 (03.06.2020) Ministerstva zdravoohraneniya Rossijskoj Federacii. https://www.rosminzdrav.ru/news/2020/06/03/14109-minzdrav-rossii-utverdil-7-versiyumetodicheskih-rekomendatsiy-po-lecheniyu-covid-19
3. Mao R, Qiu Y, He J-S, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020. Published Online May 12, 2020. doi:10.1016/S2468-1253(20)30126-6.
4. Grinevich V.B.,Kravchuk YU.A., Tkachenko E.I. i dr. Osobennosti vedeniya bol'nyh s gastro enterologicheskoj patologiej v usloviyah pandemii COVID-19. Eksperimental'naya i klinicheskaya gastroenterologiya. 2020;176(4). doi:10.31146/1682-8658-ecg-176-4.
5. Ivashkin VT, Sheptulin AA, Zolnikova OY, et al. New coronavirus infection (COVID-19) and digestive system. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 0 (In Russ.)
6. Ivashkin V.T., Zol'nikova O.YU., Ohlobystin A.V. i dr. Novaya koronavirusnaya infekciya (COVID-19) i sistema organov pishchevareniya. Rossijskij zhurnal gastroenterologii, gepatologii, koloproktologii. 2020:doi:10.22416/1382-4376-2020-30-3-7.
7. Ma C, Cong Y, Zhang H. COVID-19 and the Digestive System. Am J Gastroenterol 2020;00:1-4. doi:10.14309/ajg.0000000000000691.
8. Lin L, Jiang X, Zhang Z, at al. Gastrointestinal Symptoms of 95 Cases With SARS-CoV-2 Infection. Gut. 2020; 69(6):997-1001.doi:10.1136/gutjnl-2020-321013.
9. Pan L, Mu M, Ren HG, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020.doi:10.14309/ajg.0000000000000620.
10. Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review. World J Gastroenterol. 2020;26(19):2323-32. doi:10.3748/wjg.v26.i19.2323.
11. Suresh Kumar VC, Mukherjee S, Harne PS, et al. Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol. 2020;7(1): e000417. doi:10.1136/bmjgast-2020-000417.
12. Cheung KS, Hung IF, Chan PP. Gastr ointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis. Gastroenterology. 2020:S0016-5085(20)30448-0. doi:10.1053/j.gastro.2020.03.065.
